Iridex (IRIX) EBIT (QoQ) (2010 - 2026)
Iridex (IRIX) EBIT (QoQ) (2010 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn |
| 10 | Iridex | 13.32 Mn | 8.64 Mn | 4.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | -2,060.00% |
| Jan 3, 2026 | 98.94% |
| Sep 27, 2025 | -50.11% |
| Jun 28, 2025 | -358.54% |
| Mar 29, 2025 | 59.16% |
| Dec 28, 2024 | 73.16% |
| Sep 28, 2024 | 29.11% |
| Jun 29, 2024 | 19.89% |
| Mar 30, 2024 | -6.88% |
| Dec 30, 2023 | -82.52% |
| Sep 30, 2023 | 41.67% |
| Jul 1, 2023 | -23.46% |
| Apr 1, 2023 | -66.24% |
| Dec 31, 2022 | 16.81% |
| Oct 1, 2022 | 21.53% |
| Jul 2, 2022 | 5.14% |
| Apr 2, 2022 | -82.16% |
| Jan 1, 2022 | 42.05% |
| Oct 2, 2021 | -89.54% |
| Jul 3, 2021 | 38.19% |